Therapy Infusions | ZYNLONTA® (loncastuximab tesirine-lpyl) Patient Site

About ZYNLONTA® Infusions

About ZYNLONTA® Infusions

Not an actual patient.

ZYNLONTA®: Focus on time between treatments

ZYNLONTA® treatment icon

ZYNLONTA® (loncastuximab tesirine-lpyl) is given through a needle placed in the vein (intravenous, or IV, infusion) at a clinic or infusion center.

ZYNLONTA® was specifically studied in adult patients who needed their next diffuse large B-cell lymphoma (DLBCL) therapy, after trying 2 or more past therapies.

Diffuse Large B-Cell Lymphoma (DLBCL) — A type of B-cell non-Hodgkin lymphoma (cancer of the immune system) that is usually aggressive (fast-growing). It is the most common type of non-Hodgkin lymphoma, and is marked by rapidly growing tumors in the lymph nodes, spleen, liver, bone marrow, or other organs.

 

ZYNLONTA® worked in 48% of people in the trial. And for some it worked in about 1 month*

*In a clinical trial, 145 patients with DLBCL that has come back (relapsed) or did not respond to previous therapy (refractory) were treated with ZYNLONTA® to see how well it worked. Out of 145 people, 70 saw anti-cancer results. The median time that it took for half of people to respond was 1.3 months. It took the other half longer to respond, up to 8.1 months.
Learn about ZYNLONTA® clinical trial results.

Schedule your infusion every 3 weeks

  • ZYNLONTA® treatment icon
    ZYNLONTA® is given through
    an intravenous (IV) infusion
  • 30 minutes icon
    It takes about 30
    minutes
  • 3 weeks icon
    It is given every
    3 weeks

Your doctor will decide how many therapies you need. You’ll work with office staff to figure out the best schedule for you.

Your doctor may give you medicine before each infusion to decrease your chance of side effects.

Your doctor may give you a steroid before ZYNLONTA®

Steroid — Any of a group of lipids (fats) that have a certain chemical structure. Steroids are found in plants and animals or they may be made in the laboratory.

 
Doctor icon

Before each ZYNLONTA® treatment, you may have to take a prescription steroid (dexamethasone) to lower your chance of side effects.

Your doctor will let you know if this is needed. The steroid may be given as an oral medication or IV infusion.

  • 2 times
    a day
  • for 3 days
  • starting the day
    before
    infusion(s)

Tip: Set a reminder on your phone about your therapy/therapies. This way you can plan around your schedule

What to do if you miss a dose

Alert your doctor’s office right away to talk about your options.

Your doctor may change your treatment schedule

If you have severe side effects, your doctor may:

  • Stop your treatment icon Stop your
    treatment
  • Delay your treatment icon Delay your
    treatment
  • Change your dose icon Change your dose
    of ZYNLONTA®
    • Your doctor will also do blood tests regularly to check for side effects and keep an eye on your response to treatment while you’re on ZYNLONTA®
    • You will be monitored for infusion site reactions, infections, and skin reactions. You may also need CT scans to monitor the cancer

This may be a perfect time to catch up on some reading or to make to-do lists. Remember to listen to your body and rest as needed

Curated playlists*

Feel free to enjoy any of the curated playlists below. Or, you could also listen to your favorite artists, podcasts, meditations, and/or audiobooks.

Jazz & Classical

Download the brass and keys playlist to relax

Rock & Metal

Download and let
guitars do the talking

Ambient & World Music

Download to drift off
into meditative worlds

*Content above is provided purely for the sake of entertainment. By providing said content, ADC Therapeutics is not attempting to make any claims about results of any kind or implying that the content or activities therein are curative in any way. Always consult with your doctor’s office about any health conditions you may have and how they may best be treated. ADC Therapeutics does not own or condone, or is not accountable for any ideas or words included in external links.

Essentials for Infusion, Icon

Essentials for Infusion: Your Guide to ZYNLONTA®

This guide can help you feel prepared and informed about your infusion experience.

Download the ZYNLONTA® Treatment Guide

You could save on
ZYNLONTA® treatment

https://www.zynlonta.com/wp-content/uploads/2022/04/wallet-icon-1.png
Learn about financial support

ZYNLONTA® may cause
side effects

https://www.zynlonta.com/wp-content/uploads/2022/06/side-effect-list-icon.png
Read up on possible side effects
Expand

What is ZYNLONTA®?

Important Safety Information

ZYNLONTA® is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment (refractory), who have already received two or more treatments for their cancer.

It is not known if ZYNLONTA® is safe and effective in children.

The approval of ZYNLONTA® is based on a type of response rate. There is an ongoing study to confirm the clinical benefit of ZYNLONTA®.

Read full Important Safety Information

IMPORTANT SAFETY INFORMATION

What are the possible side effects of ZYNLONTA®?

ZYNLONTA® may cause serious side effects, including:

  • Fluid retention. Your body may hold too much fluid during treatment with ZYNLONTA®. This can be serious. Tell your healthcare provider if you develop new or worsening swelling or puffiness, weight gain, chest pain, shortness of breath, or trouble breathing
  • Low blood cell counts (platelets, red blood cells, and white blood cells). Low blood cell counts are common with ZYNLONTA® but can also be serious or severe. Your healthcare provider will monitor your blood counts during treatment with ZYNLONTA®. Tell your healthcare provider right away if you get a fever of 100.4°F (38°C) or above, or any bruising or bleeding
  • Read full Important Safety Information
  • Infections. Serious infections, including infections that can cause death, have happened in people treated with ZYNLONTA®. Tell your healthcare provider right away if you have new or worsening signs or symptoms of infection
  • Skin reactions. Serious skin reactions have happened in people treated with ZYNLONTA®. Tell your healthcare provider if you get new or worsening skin reactions, including sensitivity to sunlight, skin rash, peeling, redness or irritation. You may burn more easily or get severe sunburns

The most common side effects of ZYNLONTA® include:

  • feeling tired or weak
  • skin rash
  • swelling
  • nausea
  • muscle or joint pain
  • increase in blood sugar (hyperglycemia)
  • changes in certain blood or laboratory tests

ZYNLONTA® may cause fertility problems in males which may affect your ability to father children. Talk to your healthcare provider if this is a concern for you. These are not all of the possible side effects of ZYNLONTA®.

What should I avoid while receiving ZYNLONTA®?

Avoid or limit your exposure to sunlight, including sunlight through glass, such as buildings or vehicle windows and artificial sunlight such as sunlamps or tanning beds. Exposure to sunlight during treatment with ZYNLONTA® can cause skin reaction or rash. Use sun protection measures such as sunscreen and wear loose-fitting clothes that cover your skin while out in sunlight.

Before you receive ZYNLONTA®, tell your healthcare provider about all of your medical conditions, including if you:

  • have an active infection or have had one recently
  • have liver problems
  • are pregnant or plan to become pregnant. ZYNLONTA® can harm your unborn baby

    Females who can become pregnant:

    • your healthcare provider may do a pregnancy test before starting treatment with ZYNLONTA®
    • you should use effective birth control (contraception) during treatment with ZYNLONTA® and for 10 months after the last dose of ZYNLONTA®. Talk to your healthcare provider about effective birth control. Tell your healthcare provider right away if you become pregnant or think that you are pregnant during treatment with ZYNLONTA®

    Males with female partners who can become pregnant:

    • you should use effective birth control (contraception) during treatment with ZYNLONTA® and for 7 months after the last dose of ZYNLONTA®
  • are breastfeeding or plan to breastfeed. It is not known if ZYNLONTA® passes into breast milk. Do not breastfeed during treatment with ZYNLONTA® and for 3 months after the last dose of ZYNLONTA®

Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get new medicine.

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to ADC Therapeutics at 1-855-690-0340.

Please see the full Prescribing Information for ZYNLONTA®, including Patient Information, for additional Important Safety Information.

What is ZYNLONTA®?

Important Safety Information

ZYNLONTA® is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment (refractory), who have already received two or more treatments for their cancer.

It is not known if ZYNLONTA® is safe and effective in children.

The approval of ZYNLONTA® is based on a type of response rate. There is an ongoing study to confirm the clinical benefit of ZYNLONTA®.

Read full Important Safety Information

IMPORTANT SAFETY INFORMATION

What are the possible side effects of ZYNLONTA®?

ZYNLONTA® may cause serious side effects, including:

  • Fluid retention. Your body may hold too much fluid during treatment with ZYNLONTA®. This can be serious. Tell your healthcare provider if you develop new or worsening swelling or puffiness, weight gain, chest pain, shortness of breath, or trouble breathing
  • Low blood cell counts (platelets, red blood cells, and white blood cells). Low blood cell counts are common with ZYNLONTA® but can also be serious or severe. Your healthcare provider will monitor your blood counts during treatment with ZYNLONTA®. Tell your healthcare provider right away if you get a fever of 100.4°F (38°C) or above, or any bruising or bleeding
  • Read full Important Safety Information
  • Infections. Serious infections, including infections that can cause death, have happened in people treated with ZYNLONTA®. Tell your healthcare provider right away if you have new or worsening signs or symptoms of infection
  • Skin reactions. Serious skin reactions have happened in people treated with ZYNLONTA®. Tell your healthcare provider if you get new or worsening skin reactions, including sensitivity to sunlight, skin rash, peeling, redness or irritation. You may burn more easily or get severe sunburns

The most common side effects of ZYNLONTA® include:

  • feeling tired or weak
  • skin rash
  • swelling
  • nausea
  • muscle or joint pain
  • increase in blood sugar (hyperglycemia)
  • changes in certain blood or laboratory tests

ZYNLONTA® may cause fertility problems in males which may affect your ability to father children. Talk to your healthcare provider if this is a concern for you. These are not all of the possible side effects of ZYNLONTA®.

What should I avoid while receiving ZYNLONTA®?

Avoid or limit your exposure to sunlight, including sunlight through glass, such as buildings or vehicle windows and artificial sunlight such as sunlamps or tanning beds. Exposure to sunlight during treatment with ZYNLONTA® can cause skin reaction or rash. Use sun protection measures such as sunscreen and wear loose-fitting clothes that cover your skin while out in sunlight.

Before you receive ZYNLONTA®, tell your healthcare provider about all of your medical conditions, including if you:

  • have an active infection or have had one recently
  • have liver problems
  • are pregnant or plan to become pregnant. ZYNLONTA® can harm your unborn baby

    Females who can become pregnant:

    • your healthcare provider may do a pregnancy test before starting treatment with ZYNLONTA®
    • you should use effective birth control (contraception) during treatment with ZYNLONTA® and for 10 months after the last dose of ZYNLONTA®. Talk to your healthcare provider about effective birth control. Tell your healthcare provider right away if you become pregnant or think that you are pregnant during treatment with ZYNLONTA®

    Males with female partners who can become pregnant:

    • you should use effective birth control (contraception) during treatment with ZYNLONTA® and for 7 months after the last dose of ZYNLONTA®
  • are breastfeeding or plan to breastfeed. It is not known if ZYNLONTA® passes into breast milk. Do not breastfeed during treatment with ZYNLONTA® and for 3 months after the last dose of ZYNLONTA®

Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get new medicine.

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to ADC Therapeutics at 1-855-690-0340.

Please see the full Prescribing Information for ZYNLONTA®, including Patient Information, for additional Important Safety Information.